Prognostic Relevance of Concordant Expression CD69 and CD56 in Response to Bortezomib Combination Therapy in Multiple Myeloma Patients-Reference-Cited by-同舟云学术

Prognostic Relevance of Concordant Expression CD69 and CD56 in Response to Bortezomib Combination Therapy in Multiple Myeloma Patients

Author:

ElMenshawy Nadia¹,Farag Nora A.¹,Atia Doaa M.¹,Abousamra Nashwa¹,Shahin Doaa¹,Fawzi Eman¹,Ghazi Hayam²,El-kott Attalla F.³⁴,Eissa Mohamed⁵⁶

Affiliation:

1. Clinical Pathology Department, Hematology Unit, Mansoura Medical School, Mansoura University, Mansoura, Egypt

2. Department of Medical Oncology, Mansoura Oncology Center, Mansoura University, Mansoura, Egypt

3. Department of Biology, College of Science, King Khalid University, Saudi Arabia

4. Department of Zoology, Faculty of Science, Damanhour University, Damanhour, Egypt

5. Pathology Department, College of Medicine, King Khalid University, Abha, KSA

6. Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

Funder

Deanship of Scientific Research at King Khalid University, Abha,

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

Reference24 articles.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献